Glipizide Increases Cardiovascular Risk Compared to DPP4 Inhibitors in T2D
Drug Topics
AUGUST 5, 2025
3 “While sulfonylureas are popular and affordable diabetes medications, there is a lack of long-term clinical data on how they affect cardiac health in comparison to more neutral alternatives like dipeptidyl peptidase 4 inhibitors.”
Let's personalize your content